References
- LevineRJLamCQianCSoluble endoglin and other circulating antiangiogenic factors in pre-eclampsiaObstet Gynecol Surv2007628283
- SharonMFranklinHEpsteinSPre-eclampsia and angiogenic imbalanceAnnu Rev Med2010596178
- LevineRJLamCQianCSoluble endoglin and other circulating anti-angiogenic factors in pre-eclampsiaN Engl J Med2006355992100516957146
- CherneckyCCLaboratory Tests and Diagnostic Procedures3rd edPhiladelphia, PAWB Saunders2007
- American College of Obstetrics and Gynecology Practice BulletinDiagnosis and management of pre-eclampsia and eclampsiaObstet Gynecol20029915916716175681
- FoidartJMunautCChantraineFAkolekarRNicolaidesKHMaternal plasma soluble endoglin at 11–13 weeks’ gestation in pre-eclampsiaUltrasound Obstet Gynecol20103568068720205159
- LevineRJMaynardSEQianCCirculating angiogenic factors and the risk of pre-eclampsiaN Engl J Med200435067268314764923
- LimJHKimSYParkSYSoluble endoglin and transforming growth factor-beta1 in women who subsequently developed pre-eclampsiaPrenat Diagn20092947147619253312
- RomeroRNienJKEspinozaJA longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonateJ Matern Fetal Neonatal Med20082192318175241
- VenkateshaSToporsianMLamCSoluble endoglin contributes to the pathogenesis of pre-eclampsiaNat Med20061264264916751767
- MasuyamaHNakatsukasaHTakamotoNCorrelation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in pre-eclampsiaJ Clin Endocrinol Metab2009922672267917426083
- HirashimaCOhkuchiAAraiFEstablishing reference values for both total soluble fms-like tyrosine kinase 1 and free placental growth factor in pregnant womenHypertens Res20092872773216419645
- ToporsianMGrosRKabirMGA role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasiaCirc Res20099668469215718503
- DuhanNSharmaDGargNDahiyaKSirohiwalDComparative evaluation of serum endoglin in pre-eclampsia and normotensive pregnant womenJournal of Physiology and Pathophysiology201124751
- GuYLewisDFWangYPlacental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and pre-eclamptic pregnanciesJ Clin Endocrinol Metab20109326026617956952
- RobinsonCJJohnsonDDSoluble endoglin as a second-trimester marker for pre-eclampsiaAm J Obstet Gynecol200919717417517689640
- SalahuddinSLeeYVadnaisMDiagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancyObstetric Anesthesia Digest2010281920
- LeeHBKilKCNamSYShinJECheonJYLeeYClinical usefulness of soluble fms-like tyrosine kinase 1, soluble endoglin and placental growth factor in Korean women with pre-eclampsiaKorean J Obstet Gynecol201154229235
- FangMHeYLiHWuMShiXDuHAlterations of serum and placental endoglin in pre-eclampsiaJ Int Med Res201038435120233512
- WidmerMVillarJBenigniAConde-AgudeloAKarumanchiSALindheimerMMapping the theories of preeclampsia and the role of angiogenic factors: a systematic reviewObstet Gynecol200710916818017197602
- ChaiworapongsaTRomeroREspinozaJEvidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator AwardAm J Obstet Gynecol20041901541154715284729